The Role of Connexin43 in Diabetic Microvascular Complications

被引:0
|
作者
Li, Hui [1 ]
Wang, Fang [1 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
TO-CELL COMMUNICATION; RETINAL ENDOTHELIAL-CELLS; JUNCTION INTERCELLULAR COMMUNICATION; GLOMERULAR MESANGIAL CELLS; HIGH-GLUCOSE; DOWN-REGULATION; VASCULAR-LESIONS; FOOT ULCERS; EXPRESSION; RETINOPATHY;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Diabetes mellitus is one of the largest global healthcare problems. People with diabetes have high risk of developing any of the microvascularcomplications, including retinopathy, nephropathy, and neuropathy, which can bring much more serious psychological and economic burden for the diabetic patients. As a consequence of its microvascular complications, diabetes has become the leading cause of blindness, end-stage renal disease, and a variety of debilitating neuropathies. Although the mechanisms involved in the development and progression of these three diabetic microvascular complications are different and have not been completely elucidated, some common histopathological features like increased vascular permeability and apoptosis of specific vascular cells are shared in retinopathy and nephropathy. Moreover, epidemiological studies show a significant clinical association between diabetic retinopathy and nephropathy. Connexin43, the most abundant gap junction protein, is ubiquitously expressed in vertebrate tissues and organs including the retina and kidney. Connexin43 has been reported to play a critical role in maintaining vascular homeostasis. In this review, we highlight the role of connexin43 in diabetic microvascular complications, with special focus on diabetic retinopathy and nephropathy.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [31] Redistribution of connexin43 in endstage cardiomyopathy
    Huang, XD
    Sandusky, GE
    Pressler, ML
    Zipes, DP
    CIRCULATION, 1996, 94 (08) : 3545 - 3545
  • [32] Postnatal connexin43 in the rat brain
    Aberg, D
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S67 - S67
  • [33] Peptidomimetic inhibitors of Connexin43 hemichannels
    Iaculli, Debora
    Lamouroux, Arthur
    Montgomery, Jade
    Vinken, Mathieu
    Kwak, Brenda R.
    Ballet, Steven
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [34] Regulation of connexin43 oligomerization is saturable
    Das Sarma, J
    Das, S
    Koval, M
    CELL COMMUNICATION AND ADHESION, 2005, 12 (5-6): : 237 - 247
  • [35] Purinergic agonist regulation of connexin43
    Lurtz, MM
    Louis, CF
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 212A - 212A
  • [36] Connexin43 phosphorylation and cytoprotection in the heart
    Jeyaraman, Maya M.
    Srisakuldee, Wattamon
    Nickel, Barbara E.
    Kardami, Elissavet
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2012, 1818 (08): : 2009 - 2013
  • [37] Stimulated phosphorylation of intracellular connexin43
    Cruciani, V
    Mikalsen, SO
    EXPERIMENTAL CELL RESEARCH, 1999, 251 (02) : 285 - 298
  • [38] connexin43 gene mutations and heterotaxy
    Tóth, T
    Hajdú, J
    Marton, T
    Nagy, B
    Papp, Z
    CIRCULATION, 1998, 97 (01) : 117 - 118
  • [39] Increasing the Connexin40/Connexin43 or Connexin37/Connexin43 expression ratio reduces lucifer yellow transfer but not electrical coupling
    Gemel, J
    Nelson, TK
    Burt, JM
    Beyer, EC
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 310A - 310A
  • [40] Targeting connexin43 expression accelerates the rate of skin and diabetic wound repair
    Wang, Chiuhui Mary
    Green, Colin
    Duft, Bradford J.
    Becker, David L.
    JOURNAL OF BIOTECHNOLOGY, 2007, 131 (02) : S64 - S64